Source: Annual Congress 2003 - Supportive care in chronic respiratory failure
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Moretti, A. Potena, G. Garuti, P. Bottrighi, C. Mancini, G. Formoso (Modena, Ferrara, Piacenza, Italy). The effect of long term treatment with erdosteine on COPD: the Equalife study. Eur Respir J 2003; 22: Suppl. 45, 2743

Member's Comments

No comment yet.

Related content which might interest you: The effect of inhaled corticosteroids on the hypothalamic-pituitary-adrenal-axis in short term and long term treatment Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 The effect of long-term treatment with erdosteine on moderate or severe COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005 Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study Source: Eur Respir J, 50 (4) 1700711; 10.1183/13993003.00711-2017 Year: 2017 Long term study of pulmonary function in stable COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 197s Year: 2002 Functional effects of long term ICS treatment in controlled asthma Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients Source: Eur Respir J 2014; 44: 527-529 Year: 2014 Long term effect of doxycycline in asthma: a real world observation Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 The effect of tiotropium in the treatment of patients with COPD Source: Annual Congress 2010 - COPD: management Year: 2010 Clinical benefits and safety of long term treatment with montelukast (M) in patients with mild-to-moderate asthma Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001 Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study Source: International Congress 2018 – COPD management Year: 2018 The effect of long term low dose azithromycin on symptoms and lung function in pulmonary sarcoidosis Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008 Noneosinophilic asthma: persistence over time and effect of treatment Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006 The effects of adding in erdosteine on the routine bronchodilator therapy in moderate and severe COPD patients Source: Annual Congress 2006 - COPD therapy Year: 2006 The effects of early intervention with inhaled budesonide on lung function in mild persistent asthma: results from the START study Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003 Persistency of antioxidant/antiinflammatory effects of erdosteine treatment in COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Three month treatment with formoterol in mild asthma: efficacy and side effects Source: Eur Respir J 2001; 18: Suppl. 33, 426s Year: 2001 Short term treatment response in pulmonary sarcoidosis – a prospective study Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 A randomised controlled trial to investigate the optimal dose and effect of salbutamol for the treatment of acute exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 244s Year: 2002 Effects of N-acetylcysteine treatment during long-term oxygen therapy (LTOT) in COPD patients. An open parallel-group study Source: Eur Respir J 2001; 18: Suppl. 33, 58s Year: 2001 Does the initial BODE influence in the response at short and long term of a pulmonary rehabilitation (PR) program in COPD patients? Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease Year: 2010